$ICPT Company News This shocking strategy will save your

New Post Public Reply Private Reply Replies (0) Message Board

Jan 17, 2014 at 11:04 AM

$ICPT Company News

This shocking strategy will save your portfolio 6:01 a.m. Jan. 15, 2014 - Jeff Reeves
Alnylam shares settle down after 40% gain; analysts are skeptical 1:16 p.m. Jan. 14, 2014 - Russ Britt
Intercept, Intuitive take diverging paths on the market roller coaster 10:51 a.m. Jan. 14, 2014 - Russ Britt
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:18 p.m. Jan. 13, 2014 - Sue Chang
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - Russ Britt
Intercept, Lululemon, SodaStream shares slump 10:22 a.m. Jan. 13, 2014 - Saumya Vaishampayan
S&P 500 gains for week; builder stocks rally as yields fall; the wonder of liver-drug stocks (live blog recap) 10:15 a.m. Jan. 13, 2014 - blogs.marketwatch.com
Clovis Oncology, seen as 'next ICPT,' jumps 5% 9:47 a.m. Jan. 13, 2014 - Victor Reklaitis
Intercept shares trip short-sale circuit breaker 9:32 a.m. Jan. 13, 2014 - Laura Mandaro
Intercept, Celgene on move amid J.P. Morgan event 9:20 a.m. Jan. 13, 2014 - Victor Reklaitis
Banks, hedge funds and what Citi has to tell its rich clients 7:47 a.m. Jan. 13, 2014 - Shawn Langlois
Alcoa tops S&P losers, Twitter extends losing streak 4:29 p.m. Jan. 10, 2014 - Sue Chang
Macy’s up on restructuring; Apple and Samsung to talk 4:40 p.m. Jan. 9, 2014 - Sue Chang
Stock record? Intercept Pharma up nearly 300% on drug test results 2:14 p.m. Jan. 9, 2014 - Russ Britt
Intercept Pharma, Kythera take off in IPOs 10:53 a.m. Oct. 11, 2012 - MarketWatch.com
Intercept Pharma, Kythera take off in IPOs 10:34 a.m. Oct. 11, 2012 - MarketWatch.com
In the IPO desert, Thursday brings rain 9:42 a.m. Oct. 11, 2012 - MarketWatch
Intercept Pharma 5M-share IPO prices at high end 7:06 a.m. Oct. 11, 2012 - MarketWatch.com
Stocks to watch Thursday: Ruby Tuesday, Realogy 5:44 a.m. Oct. 11, 2012 - MarketWatch

5 Dumbest Things on Wall Street This Week 7:00 a.m. Today - TheStreet.com
3 Critical Factors For Intercept Bulls Now 4:02 a.m. Jan. 16, 2014 - Seeking Alpha
Athersys: Why Did Shareholders Come Knocking At The Door Once Again? 3:15 p.m. Jan. 15, 2014 - Seeking Alpha
Intercept Pharma cools off after presentation 11:04 a.m. Jan. 15, 2014 - Seeking Alpha
Today's Dead Cat Bounce Stock Is Intercept Pharmaceuticals (ICPT) 9:45 a.m. Jan. 15, 2014 - TheStreet.com
Intercept rallies ahead of conference, BofA defends lofty target 8:29 a.m. Jan. 15, 2014 - Seeking Alpha
Hot New Biotech Knows Roller-Coaster Feeling 7:49 p.m. Jan. 14, 2014 - WSJ.com
Intercept Pharmaceuticals Inc (ICPT): Today's Featured Drugs Laggard 5:01 p.m. Jan. 14, 2014 - TheStreet.com
Intercept Pharma falls again as article strikes cautious tone 11:07 a.m. Jan. 14, 2014 - Seeking Alpha
The Short Story Of Intercept Pharmaceuticals (Part I): A Conference Call With Expert Physicians 10:20 a.m. Jan. 14, 2014 - Seeking Alpha
ICPT: Time to Catch a Rising Star With Intercept Stock? 8:34 a.m. Jan. 14, 2014 - InvestorPlace.com
SA PRO: Top Long And Short Ideas, Monday January 13 7:30 a.m. Jan. 14, 2014 - Seeking Alpha
'Fast Money' Recap: The Economy and the Market 5:00 a.m. Jan. 14, 2014 - TheStreet.com
XBI – Be Careful With This Biotech ETF After Its Violent Breakout 3:00 a.m. Jan. 14, 2014 - InvestorPlace.com
Biotech Stocks Back On Top, Led By Biogen, Alexion 5:07 p.m. Jan. 13, 2014 - Investors Business Daily
Watch Out for Mr. Downside 4:18 p.m. Jan. 13, 2014 - RealMoney.com
Weak Action Threatens to Spread 1:10 p.m. Jan. 13, 2014 - RealMoney.com
Summer Street shrugs off Intercept Pharma LDL concerns 11:58 a.m. Jan. 13, 2014 - Seeking Alpha
A Sleepy Start to the Week 10:56 a.m. Jan. 13, 2014 - RealMoney.com
Good News Continues to Roll in for CytRx 9:59 a.m. Jan. 13, 2014 - Wall St. Cheat Sheet

Harwood Feffer LLP Announces Investigation of Intercept Pharmaceuticals, Inc. 8:00 p.m. Jan. 15, 2014 - PR Newswire - PRF
Shareholder Rights Law Firm Johnson & Weaver, LLP Announces Investigation of Intercept Pharmaceuticals, Inc. 2:03 p.m. Jan. 14, 2014 - BusinessWire - BZX
Small Cap Buzz: GW Pharmaceuticals, Intercept Pharmaceuticals, Medbox Inc, GreenGro Technologies 11:19 a.m. Jan. 13, 2014 - ACCESSWIRE
Intercept Reports Additional Details About FLINT Trial Provided by NIDDK 6:06 p.m. Jan. 12, 2014 - GlobeNewswire
Intercept to Present at the J.P. Morgan Healthcare Conference 6:31 p.m. Jan. 10, 2014 - GlobeNewswire
Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones 4:05 p.m. Jan. 9, 2014 - GlobeNewswire
Intercept Provides 2013 Year-End Update and 2014 Anticipated Milestones 4:05 p.m. Jan. 9, 2014 - GlobeNewswire
Intercept Announces NASH Primary Endpoint Met: FLINT Trial Stopped Early for Efficacy Based on Highly Statistically Significant Improvement in Liver Histology 7:33 a.m. Jan. 9, 2014 - GlobeNewswire
Intercept Pharmaceuticals to Provide 2013 Update on Clinical Programs for Obeticholic Acid on January 9 4:05 p.m. Jan. 2, 2014 - GlobeNewswire
Healthcare Companies Report Interim Data, Clinical Study Results, and Announcements - Research Report on Pfizer, Coronado Biosciences, Spectranetics, Celsion, and Intercept 8:00 a.m. Dec. 18, 2013 - PR Newswire
INTERCEPT PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Intercept Pharmaceuticals, Inc. Regarding Possible Breaches of Fiduciary Duty 6:31 p.m. Dec. 9, 2013 - PR Newswire
Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals 8:00 a.m. Nov. 20, 2013 - PR Newswire
Intercept Pharmaceuticals Reports Third Quarter 2013 Financial Results 6:05 a.m. Nov. 14, 2013 - PR Newswire
Trial Results Presentations, Public Offerings, Acquisitions and Extension Study Results - Research Report on Medtronic, Steris, Intercept, Wright, and Synageva 7:00 a.m. Oct. 23, 2013 - PR Newswire
Intercept Announces Pricing of Public Offering of Common Stock By Selling Stockholders 8:02 p.m. Oct. 8, 2013 - PR Newswire
Keryx Biopharmaceuticals, Inc. Announces Appointment of Daniel P. Regan to Board of Directors 7:30 a.m. Oct. 4, 2013 - GlobeNewswire
Business Strategy, Partnerships, Presentation, and Appointment - Research Report on Merck, GSK, Sanofi, Intercept, and KYTHERA 7:00 a.m. Oct. 4, 2013 - PR Newswire
Additional Results of Global Primary Biliary Cirrhosis Study Group Analysis to be Presented at AASLD Annual Meeting 3:05 p.m. Oct. 1, 2013 - PR Newswire
Intercept Pharmaceuticals Reports Second Quarter 2013 Financial Results 5:00 a.m. Aug. 13, 2013 - PR Newswire
Intercept Pharmaceuticals to Present at the Wedbush Securities Life Sciences Management Access Conference 5:00 a.m. Aug. 5, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

iTLC Traffic Systems Expand Global Reach at APTA 2026

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Main Street Merger Faces Scrutiny: What It Means for Shareholders

Under the Radar, but Not for Long Ah, mergers—those grand gestures in corporate America that promise growth, synergy, and shareholder value. But not every deal is a head-turner; some fly under the radar until someone grabs the magnifying glass. And that's exactly what's happening with Main Street Financial Services Corp.'s (OTC: MSWV) proposed merger with First...

China-Malaysia Youth Dialogue: Tackling Ocean Challenges

Building Bridges Across Waters These aren't the afternoons of trading stocks, folks—this one dives into the depths of the ocean and the tumultuous waters between China and Malaysia. October 30 saw the China-Malaysia Youth Ocean Dialogue take place at the China Media Group Sanya Studio, bringing together some sharp minds from both nations, tackling something that goes...

UBCF Strikes Big in Times Square with New Billboards

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

NABEP's Strategic Push: 41 Rigs to Bolster Output

On The Ground: NABEP's Expanding Venezuelan Presence Think of oil production as a high-stakes poker game where each drill and rig is a well-placed bet. North American Blue Energy Partners (NABEP) is going all in on Venezuela, boosting their rig fleet and pushing production capacity to new heights. Set your sights on November when NABEP's in-country fleet will hit 41 rigs...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

Zhimeng Biopharma Hits Key Milestone in ALS Drug Trial

Pivotal Point for Zhimeng's ALS Efforts Folks, get this—Zhimeng Biopharma's rolling out the big guns here with a significant step forward in their ALS treatment quest. This company just wrapped up patient enrollment for their next-gen ALS drug, CB03-154. We're talking about 255 patients now on board for a Phase 2/3 trial. The ground's shaking a bit because this...

HanAll F&B Pioneers New Path for Domestic Rice Noodles

New Spin on an Old Favorite: Rice Noodles Forget about the same old wheat noodles clogging up the pantry. HanAll F&B is revamping the noodle game with a homegrown twist, setting sights on a future where Korean rice isn't just for steaming, soup, or sushi. This outfit from Taebaek, Gangwon, has got its hands deep in the rice flour, finessing a patent that aims to make...

Bass Angler Matt Robertson Reels in Record $1.25M Prize

A New Era for Bass Fishing Payouts Who would have thought we'd see the day when bass fishing turned out to be as lucrative as a Wall Street handshake? But here we are, with Matt Robertson hauling in a whopping $1.25 million prize at World Bass Enterprises' first "The Champions" Tournament. We're not talking chump change here—this is the real deal in a sport often...

NIDS Aims Global with CES 2027, Boosts Sensor Supply

Pushing Boundaries at CES 2027 Kicking into high gear, NIDS Co., Ltd. is eyeing the CES 2027 stage like it's their personal gold rush. Already a heavyweight in environmental sensors, the company is all set to seize fresh international opportunities and expand their B2B supply footprint worldwide. Already Turning Heads Founded back in 2000, NIDS ain't new to the sensor...